
How Your Menstrual Cycle May Affect Blood Sugar and Insulin Needs
A new study shows that women with Type 1 diabetes using automated insulin pumps experience measurable changes in carbohydrate cravings, insulin requirements, and blood sugar control across different phases of their menstrual cycle.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- In the week before menstruation, women in the study ate more carbohydrates and needed more insulin overall—both basal (background) and bolus (mealtime) doses.
- Time in range (the percentage of time blood sugar stayed in target) was lower in the pre-menstrual week compared to the week of menstruation, even with the extra insulin.
- These patterns were tracked using the MiniMed 780G automated insulin delivery system and continuous glucose monitoring data.
- Understanding these cycle-related changes may help you recognize patterns in your own blood sugar management and plan ahead.
Why This Study Matters
Managing Type 1 diabetes is complex, and hormonal changes throughout the month add another layer of difficulty. Many women report feeling like their blood sugar is harder to control at certain times of the cycle, but hard data on this has been limited. This new research provides concrete evidence of how menstrual cycle phases affect insulin needs and carbohydrate intake in women using modern automated pump technology.
What the Study Found
Researchers followed 15 women (average age 35.9 years) using the MiniMed 780G system over 118 menstrual cycles. They compared two time periods: the week before menstruation and the week during menstruation.
In the pre-menstrual week, women ate significantly more carbohydrates—about 0.164 grams per kilogram of body weight more per day. This lines up with what many women experience: increased cravings and appetite just before their period.
Their bodies also demanded more insulin across the board. Total daily insulin doses were higher by about 0.029 units per kilogram of body weight. Both basal insulin (the steady, background dose) and bolus insulin (the dose given with meals) increased.
Despite using more insulin, time in range—the percentage of time blood sugar stayed between 3.9 and 10 mmol/L (70–180 mg/dL)—dropped by about 3.5 percentage points in the pre-menstrual week. In practical terms, this means blood sugar was harder to keep in target, even with the additional insulin.
What This Means for You
If you've noticed that your blood sugar feels more unpredictable or your appetite increases in the days leading up to your period, you're not imagining it. These changes are real and measurable, tied to the natural hormonal fluctuations of your cycle.
Tracking your own patterns—using your pump data, continuous glucose monitor, and notes about your cycle—can help you spot when these changes happen for you personally. Some women find it helpful to plan ahead: knowing that carb intake and insulin needs may increase, you can prepare snacks, adjust your expectations for time in range, and avoid frustration.
If you use an automated insulin delivery system like the one in this study, your pump is already collecting this data. Many women find value in reviewing their CareLink portal or similar downloads to see their own cycle patterns over several months.
Important Notes
This study looked at patterns across a group of women using one specific automated pump system. Your individual experience may differ. Factors like stress, sleep, exercise, and other hormonal changes can also affect your blood sugar alongside your menstrual cycle.
The study is observational, meaning it identified patterns but did not test any intervention or treatment. More research is needed to confirm these findings in larger, more diverse groups and to explore whether specific strategies can help manage these cycle-related changes.
If you're interested in tracking your own menstrual cycle and blood sugar patterns, discuss it with your diabetes care team. They can help you interpret your data and adjust your management plan if needed.
Evidence label
Source: Diabetes, obesity & metabolism. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DWhat We're Learning About Diabetic Ketoacidosis in Type 1 Diabetes: A French StudyPubMed indexed literature
- Living With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Living With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Living With T1DMenopause and Type 1 Diabetes: What Women Need to KnowPubMed indexed literature
- Living With T1DThe Promise and Challenge of Oral Insulin: Where the Research StandsPubMed indexed literature
- Living With T1DYour Glucose Range May Not Be the Guideline Range—And That's Worth UnderstandingPubMed indexed literature